GW Henssler & Associates Ltd. cut its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 28.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,821 shares of the biotechnology company’s stock after selling 5,500 shares during the quarter. GW Henssler & […]
Ironwood Pharmaceuticals (NASDAQ:IRWD) Cut to Hold at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Brandywine Global Investment Management LLC lowered its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 1.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 476,559 shares of the biotechnology company’s stock after selling 5,429 shares during the […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Equities research analysts at Zacks Research lifted their Q2 2025 earnings per share estimates for shares of Ironwood Pharmaceuticals in a report issued on Monday, September 25th. Zacks Research analyst A. Chakraborty now forecasts that the biotechnology company will post earnings of $0.23 per share for the […]
StockNews.com lowered shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) from a strong-buy rating to a buy rating in a research note released on Thursday. Separately, Piper Sandler upped their price target on Ironwood Pharmaceuticals from $16.00 to $19.00 in a research report on Tuesday, May 23rd. Ironwood Pharmaceuticals Stock Performance Shares of IRWD stock […]